British Journal of Cancer - Table of Contents alert Volume 106 Issue 2

TABLE OF CONTENTS Volume 106, Issue 2 (241-428) Published online 17 January 2012 In this issue Editorial Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Letters to the Editor Also new today Advance online publication Advertisement 13th Milan Breast Cancer Conference We look forward to meeting you in Milan (Italy) from 22nd to 24th June 2011. For more information please visit the website www.breastmilan.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer presents: Web Focus on MicroRNA MicroRNAs have emerged as major new mechanisms of regulation of gene function, potential therapeutic targets, with roles in diagnosis, prognosis and biomarkers. This collection puts MicroRNA in context of other molecular classifications and then investigative articles and reviews cover the main tumour types where microRNAs are emerging as having important roles in biological processes including lung cancer, AML, melanoma, colorectal cancer, nasopharyngeal carcinoma, bladder cancer, rhabdomyosarcoma and heptacellular carcinoma. Read the articles for FREE   Editorial Top Treating cancer with amplitude-modulated electromagnetic fields: a potential paradigm shift, again? C F Blackman Br J Cancer 2012 106: 241-242; 10.1038/bjc.2011.576 Full Text Minireviews Top The role of EZH2 in tumour progression C-J Chang and M-C Hung Br J Cancer 2012 106: 243-247; advance online publication, December 20, 2011; 10.1038/bjc.2011.551 Abstract | Full Text Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research N Shenker and J M Flanagan Br J Cancer 2012 106: 248-253; advance online publication, December 13, 2011; 10.1038/bjc.2011.550 Abstract | Full Text Genetic and proteomic approaches to identify cancer drug targets G Roti and K Stegmaier Br J Cancer 2012 106: 254-261; advance online publication, December 13, 2011; 10.1038/bjc.2011.543 Abstract | Full Text Clinical Studies Top Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia P J Byrd, V Srinivasan, J I Last, A Smith, P Biggs, E F Carney, A Exley, C Abson, G S Stewart, L Izatt and A M Taylor Br J Cancer 2012 106: 262-268; advance online publication, December 6, 2011; 10.1038/bjc.2011.534 Abstract | Full Text Cytology of the vulva: feasibility and preliminary results of a new brush L C G van den Einden, J M M Grefte, I A M van der Avoort, J E M Vedder, L C L T van Kempen, L F A G Massuger and J A de Hullu Br J Cancer 2012 106: 269-273; advance online publication, December 1, 2011; 10.1038/bjc.2011.533 Abstract | Full Text Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer C F Jehn, L Böning, H Kröning, K Possinger and D Lüftner Br J Cancer 2012 106: 274-278; advance online publication, January 3, 2012; 10.1038/bjc.2011.554 Abstract | Full Text Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems G W A Lamb, M Aitchison, S Ramsey, S L Housley and D C McMillan Br J Cancer 2012 106: 279-283; advance online publication, December 13, 2011; 10.1038/bjc.2011.556 Abstract | Full Text Targeting the Endothelin Axis with Atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma G Groenewegen, M Walraven, J Vermaat, B de Gast, E Witteveen, R Giles, J Haanen and E Voest Br J Cancer 2012 106: 284-289; advance online publication, January 3, 2012; 10.1038/bjc.2011.515 Abstract | Full Text Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma N Tanaka, A Miyajima, E Kikuchi, K Matsumoto, M Hagiwara, H Ide, T Kosaka, T Masuda, S Nakamura and M Oya Br J Cancer 2012 106: 290-296; advance online publication, December 20, 2011; 10.1038/bjc.2011.565 Abstract | Full Text Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival? B Bjerkehagen, M C Småstuen, K S Hall, S Skjeldal, S Smeland and S D Fosså Br J Cancer 2012 106: 297-306; advance online publication, December 15, 2011; 10.1038/bjc.2011.559 Abstract | Full Text Translational Therapeutics Top Cancer cell proliferation is inhibited by specific modulation frequencies J W Zimmerman, M J Pennison, I Brezovich, N Yi, C T Yang, R Ramaker, D Absher, R M Myers, N Kuster, F P Costa, A Barbault and B Pasche Br J Cancer 2012 106: 307-313; advance online publication, December 1, 2011; 10.1038/bjc.2011.523 Abstract | Full Text The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation C R Isham, J D Tibodeau, A R Bossou, J R Merchan and K C Bible Br J Cancer 2012 106: 314-323; advance online publication, December 20, 2011; 10.1038/bjc.2011.522 Abstract | Full Text Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase M P Kelly, A A Jungbluth, B-W Wu, J Bomalaski, L J Old and G Ritter Br J Cancer 2012 106: 324-332; advance online publication, December 1, 2011; 10.1038/bjc.2011.524 Abstract | Full Text Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment B Taylor-Harding, H Agadjanian, H Nassanian, S Kwon, X Guo, C Miller, B Y Karlan, S Orsulic and C S Walsh Br J Cancer 2012 106: 333-343; advance online publication, December 13, 2011; 10.1038/bjc.2011.546 Abstract | Full Text Molecular Diagnostics Top Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype P Karihtala, S Kauppila, U Puistola and A Jukkola-Vuorinen Br J Cancer 2012 106: 344-347; advance online publication, November 22, 2011; 10.1038/bjc.2011.518 Abstract | Full Text The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer N Otto, P Schulz, A Scholz, P Hauff, B Schlegelberger, K M Detjen and B Wiedenmann Br J Cancer 2012 106: 348-357; advance online publication, December 6, 2011; 10.1038/bjc.2011.521 Abstract | Full Text Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx E Junor, G Kerr, A Oniscu, S Campbell, I Kouzeli, C Gourley and K Cuschieri Br J Cancer 2012 106: 358-365; advance online publication, December 6, 2011; 10.1038/bjc.2011.542 Abstract | Full Text The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer S B Villadsen, J B Bramsen, M S Ostenfeld, E D Wiklund, N Fristrup, S Gao, T B Hansen, T I Jensen, M Borre, T F Ørntoft, L Dyrskjøt and J Kjems Br J Cancer 2012 106: 366-374; advance online publication, November 22, 2011; 10.1038/bjc.2011.520 Abstract | Full Text The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy R E Payne, N L Hava, K Page, K Blighe, B Ward, M Slade, J Brown, D S Guttery, S A A Zaidi, J Stebbing, J Jacob, E Yagüe, J A Shaw and R C Coombes Br J Cancer 2012 106: 375-382; advance online publication, December 13, 2011; 10.1038/bjc.2011.537 Abstract | Full Text Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer Z M A Mohammed, D C McMillan, B Elsberger, J J Going, C Orange, E Mallon, J C Doughty and J Edwards Br J Cancer 2012 106: 383-388; advance online publication, January 3, 2012; 10.1038/bjc.2011.569 Abstract | Full Text Genetics and Genomics Top Combined effect of low-penetrant SNPs on breast cancer risk S Harlid, M I L Ivarsson, S Butt, E Grzybowska, J E Eyfjörd, P Lenner, A Försti, K Hemminki, J Manjer, J Dillner and J Carlson Br J Cancer 2012 106: 389-396; advance online publication, November 1, 2011; 10.1038/bjc.2011.461 Abstract | Full Text High frequency of complex TP53 mutations in CNS metastases from breast cancer C Lo Nigro, D Vivenza, M Monteverde, L Lattanzio, O Gojis, O Garrone, A Comino, M Merlano, P R Quinlan, N Syed, C A Purdie, A Thompson, C Palmieri and T Crook Br J Cancer 2012 106: 397-404; advance online publication, December 20, 2011; 10.1038/bjc.2011.464 Abstract | Full Text Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer S Kojima, T Chiyomaru, K Kawakami, H Yoshino, H Enokida, N Nohata, M Fuse, T Ichikawa, Y Naya, M Nakagawa and N Seki Br J Cancer 2012 106: 405-413; advance online publication, November 8, 2011; 10.1038/bjc.2011.462 Abstract | Full Text DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma M Brait, L Maldonado, S Begum, M Loyo, D Wehle, F F Tavora, L H J Looijenga, J Kowalski, Z Zhang, E Rosenbaum, S Halachmi, G J Netto and M O Hoque Br J Cancer 2012 106: 414-423; advance online publication, November 8, 2011; 10.1038/bjc.2011.468 Abstract | Full Text Letters to the Editor Top Two types of fatigue in cancer patients A Giacalone, M Spina, M Berretta and U Tirelli Br J Cancer 2012 106: 424; advance online publication, January 3, 2012; 10.1038/bjc.2011.528 Full Text Reply: Two types of fatigue in cancer patients S Singer and A Brown Br J Cancer 2012 106: 425; advance online publication, January 3, 2012; 10.1038/bjc.2011.529 Full Text EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain? R Sesboüé, F Le Pessot, F Di Fiore and T Frebourg Br J Cancer 2012 106: 426-427; advance online publication, December 20, 2011; 10.1038/bjc.2011.570 Full Text Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain? A Ålgars, M Lintunen, O Carpén, R Ristamäki and J Sundström Br J Cancer 2012 106: 428; advance online publication, December 20, 2011; 10.1038/bjc.2011.571 Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.